Suvoda Executive and Leadership Team

Jagath Wanninayake, the Chief Executive Officer at Suvoda, directs the overarching corporate strategy to transform clinical trials through advanced Interactive Response Technology. By aligning product development with the evolving needs of biopharmaceutical companies, the Chief Executive Officer ensures the platform remains the industry standard for complex patient randomization and supply chain management. This leadership role involves constant engagement with the Board to secure long-term growth and market penetration. Jagath Wanninayake maintains a focus on scaling the organization to support global research initiatives, ensuring that every clinical trial benefits from robust, configurable technology. Through rigorous oversight of company-wide performance metrics, the Chief Executive Officer drives operational excellence across all departments. Ultimately, Wanninayake fosters a culture of innovation that empowers customers to prioritize patient outcomes while navigating the intricacies of modern clinical research.

Brian Greenfield, the Chief Financial Officer at Suvoda, manages the fiscal health and capital allocation strategies necessary to sustain rapid SaaS growth. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company maintains the resources required to support complex clinical trial infrastructure. This role involves close collaboration with executive leadership to evaluate investment opportunities in new technology features and global market expansion. Brian Greenfield monitors cash flow and budgetary discipline to optimize operational efficiency across all international offices. By providing data-driven insights into financial performance, the Chief Financial Officer enables informed decision-making regarding long-term business sustainability. Greenfield secures the financial foundation that allows the organization to deliver high-quality advisory services to biopharmaceutical clients, ensuring that fiscal strategies remain perfectly aligned with the broader mission of improving clinical trial outcomes through superior technological solutions.

Jp Samar, the Chief Financial Officer & Founder at Suvoda, focuses on the long-term capital structure and investor relations that support the company's mission. As a founder, the Chief Financial Officer & Founder provides historical context and strategic guidance to ensure the organization remains true to its core values while scaling. This role involves evaluating the financial impact of new product innovations and market expansion efforts. Jp Samar monitors the economic health of the business to ensure sufficient liquidity for ongoing research and development. By maintaining strong relationships with stakeholders, the Chief Financial Officer & Founder secures the necessary support for future growth initiatives. Samar oversees the integration of financial systems that track the performance of clinical trial supply chain solutions. Through a combination of financial expertise and entrepreneurial vision, the Chief Financial Officer & Founder ensures the company continues to lead the industry in providing reliable, technology-driven clinical trial support.

John Samar, the Chief Financial Officer & Founder at Suvoda, manages the strategic financial planning and corporate governance frameworks that underpin the company's operations. As a founder, the Chief Financial Officer & Founder concentrates on the development of financial models that support the deployment of Interactive Response Technology across global clinical trials. This role involves assessing the profitability of various service offerings and optimizing the cost structure to maximize value for biopharmaceutical clients. John Samar oversees the reporting processes that provide transparency to the board and investors. By analyzing the financial implications of complex study designs, the Chief Financial Officer & Founder ensures that the company remains competitive in the SaaS market. Samar drives the implementation of fiscal policies that promote sustainable growth and operational efficiency. Through deep industry knowledge and financial leadership, the Chief Financial Officer & Founder secures the resources needed to advance the company's mission of transforming clinical research.

Robert Hummel, the Chief Operating Officer at Suvoda, directs the day-to-day operations and service delivery models that support complex clinical trial designs. Overseeing the implementation of Interactive Response Technology, the Chief Operating Officer ensures that every client receives high-quality advisory services and technical support. This role involves managing the global infrastructure required to maintain system reliability and performance for biopharmaceutical customers. Robert Hummel optimizes internal workflows to increase the speed and accuracy of clinical trial supply chain management. By coordinating with engineering and customer success teams, the Chief Operating Officer guarantees that the platform meets the rigorous demands of innovative study designs. Hummel drives operational scalability, allowing the company to expand its footprint across diverse international markets. Through a focus on process improvement and service excellence, the Chief Operating Officer ensures that the organization consistently delivers on its promise to simplify the clinical trial experience.

Yuko Fukasaku, the President, Suvoda (Japan) at Suvoda, directs all regional operations and market expansion efforts within the Japanese clinical research landscape. Overseeing the localization of Interactive Response Technology, the President, Suvoda (Japan) ensures that the platform meets the specific regulatory and operational requirements of the local biopharmaceutical industry. This role involves building a high-performing team to provide exceptional customer and advisory services to regional clients. Yuko Fukasaku manages the strategic growth of the business in this key market, ensuring that the company's solutions are effectively integrated into local clinical trials. By fostering relationships with regional research organizations, the President, Suvoda (Japan) drives adoption of the company's technology. Fukasaku monitors regional performance metrics and adapts operational strategies to maintain a competitive edge. Through dedicated leadership and market expertise, the President, Suvoda (Japan) expands the company's global footprint and supports the mission of transforming clinical trials through technology.

Kelly Snow, the Chief of Staff at Suvoda, coordinates cross-functional initiatives to ensure seamless execution of the company's strategic objectives. Managing the flow of information between the executive team and various departments, the Chief of Staff facilitates alignment on critical projects related to Interactive Response Technology. This role involves streamlining internal processes to enhance productivity and communication across global teams. Kelly Snow oversees the implementation of high-priority programs that support the organization's commitment to clinical trial success. By identifying operational bottlenecks and proposing effective solutions, the Chief of Staff improves organizational agility. Snow maintains a focus on driving accountability and ensuring that all business units operate in harmony with the corporate vision. Through meticulous project management and stakeholder engagement, the Chief of Staff enables the leadership team to focus on scaling the business and delivering exceptional value to biopharmaceutical partners.

Elena Filimonova, the Chief Marketing Officer at Suvoda, architects the global brand strategy and market positioning for the company's innovative SaaS platform. Overseeing lead generation, content strategy, and industry engagement, the Chief Marketing Officer ensures that biopharmaceutical companies recognize the value of the Interactive Response Technology system. This role involves analyzing market trends to tailor messaging for diverse clinical research organizations. Elena Filimonova drives demand for the platform by highlighting the benefits of configurable features and advanced reporting capabilities. By collaborating with sales and product teams, the Chief Marketing Officer aligns marketing campaigns with the company's growth objectives. Filimonova manages the brand's presence at major industry events and digital channels, expanding the reach of the organization into new geographic territories. Through strategic communication and market analysis, the Chief Marketing Officer strengthens the company's reputation as a leader in transforming clinical trials through technology.

Andrew Prangle, the Account Executive & Chief Revenue Officer, Partnerships at Suvoda, directs the expansion of strategic alliances and revenue-generating partnerships within the biopharmaceutical sector. Overseeing the development of collaborative relationships with clinical research organizations, the Account Executive & Chief Revenue Officer, Partnerships ensures that the company's Interactive Response Technology reaches a broader client base. This role involves identifying new market opportunities and negotiating agreements that drive long-term revenue growth. Andrew Prangle manages the sales pipeline for key accounts, ensuring that clients receive tailored solutions for their clinical trial needs. By fostering strong connections with industry partners, the Account Executive & Chief Revenue Officer, Partnerships enhances the company's market presence. Prangle coordinates with the product team to ensure that partnership requirements are integrated into the platform's roadmap. Through proactive business development and relationship management, the Account Executive & Chief Revenue Officer, Partnerships secures the company's position as a preferred partner for innovative clinical trials.